Latest News
November 7, 2017
Pique Therapeutics Announces Positive Results in Phase 2 Clinical Trial of Lead Immunotherapy for Non-Small Cell Lung Cancer (PR)
February 10, 2015
Arcato Laboratories Selected as Finalist in National Business Plan Competition (PR)
March 5, 2013
Pique Therapeutics Reaches 50 Patients in Phase 2 Clinical Trial of PT 107 in Non-Small Cell Lung Cancer (PR)
November 21, 2011
A New Hope for Lung Cancer (video)
June 7, 2011
Arcato Laboratories Announces Formation, Seed Financing from Golden Pine Ventures (PR)
March 9, 2011
Pique Therapeutics Launches Phase 2 Clinical Trial of PT107 in Non-Small Cell Lung Cancer (PR)
November 17, 2010
Golden Pine Ventures Portfolio Companies Receive Grants Under the Qualifying Therapeutic Discovery Project Program (PR)
November 17, 2010
Pique Therapeutics Receives Grant Under the Qualifying Therapeutic Discovery Project Program (PR)
October 1, 2010
Kylin - Expediting RNA Delivery with Small Parcels (Gen Eng News)
August 31, 2010
Catena Pharmaceuticals Selected to Present at BIO Investor Forum (BIO)
June 30, 2010
RNA Therapeutics Expert Joins Kylin's Scientific Advisory Board (PR)
May 6, 2010
Kylin Appoints Director of Research & Development (PR)
April 6, 2010
Catena Pharmaceuticals's Co-Founders Receive Inventors of the Year Award (PR)
April 6, 2010
Kylin Announces New Patent Surrounding pRNAi Technology (PR)
December 1, 2009
Pique Therapeutics and Technomark Life Sciences Sign Co-Development and License Agreement for PT 107 (PR)
Oct 13, 2009
Kylin Sees Potential for pRNA with Aptamers, But Keeps Its Eye on RNA Interference (GenomeWeb)
Oct 8, 2009
Catena Selected to Present at Southeastern BIO Investor Forum (SEBIO)
Oct 6, 2009
Kylin Therapeutics Receives Notice of Allowance for Key Therapeutic RNA Patent Covering pRNAi (PR)
June 10, 2009
Cancer Firm "Piques" Investor Interest with Series A (BioWorld)
June 9, 2009
Pique Therapeutics Raises Series A Round of Financing (PR)
June 9, 2009
Piedmont Angel Network Invests in Pique Therapeutics (PR)
June 8, 2009
Pete Meldrum Inducted into Utah Technology Council Hall of Fame (PR)
June 1, 2009
Exigent Pharmaceuticals Among 2009 Tech 50, Most Promsing Technology Companies (TechJournalSouth)
April 13, 2009
Catena Pharmaceuticals Emerging Company Profile (BioCentury)
March 5, 2009
Catena Pharmaceuticals Selected to Present at CED's Venture 2009 Conference April 22-23 (NCCED)
March 4, 2009
Purdue University Venture Fund Invests in Kylin Therapeutics (Journal & Courier)
March 3, 2009
Catena Pharmaceuticals Selected to Present at BIO's National Venture Capital Conference March 31-April 1 (BIO)
February 2, 2009
Exigent Pharmaceuticals Wants to Beat Drug-Resistant Bugs (TechJournal South)
January 23, 2009
Catena Pharmaceuticals Selected to Present at WBT Showcase March 23-24, 2009 (WBT Showcase)
January 8, 2009
Kylin Lands $1.2MM Grant from State of Indiana (Journal & Courier)
[GPV News Archives]
[Portfolio Company News Archives]
